文献速递新发突发、热带与寄生虫病

2013-2019年美国宫本疏螺旋体所致硬蜱回归热特征

Characteristics of Hard Tick Relapsing Fever Caused by Borrelia miyamotoi, United States, 2013-2019.
PubMed 文献 · Emerg Infect Dis · 2023-01-01

基于美国东北部和中西部9个州卫生部门的公共卫生监测,2013-2019年共识别300例宫本疏螺旋体硬蜱回归热病例,其中166例(55%)为确诊病例、134例(45%)为可能病例;患者中位年龄52岁(范围1-86岁),52%为男性,70%的病例发生于6-9月、8月为高峰;发热和头痛常见,28%报告反复发热、55%有关节痛、16%有皮疹,13%住院,无死亡报告。

要点

  • 2013-2019年监测共识别300例宫本疏螺旋体硬蜱回归热,其中166例(55%)确诊、134例(45%)可能。
  • 多数病例(70%)发生于6-9月,8月为高峰;患者中位年龄52岁(范围1-86岁),52%为男性。
  • 常见症状为发热和头痛,28%报告反复发热、55%有关节痛、16%有皮疹;13%住院,无死亡报告。

核心结论

  • 持续监测将增进对宫本疏螺旋体硬蜱回归热这一新发疾病发病率和临床严重程度的了解。

研究设计与样本

  • 美国东北部和中西部9个州卫生部门使用共享的工作监测病例定义,对2013-2019年宫本疏螺旋体硬蜱回归热开展公共卫生监测。
  • 2013-2019年监测期间共识别300例病例,其中166例(55%)分类为确诊病例、134例(45%)分类为可能病例。

主要发现

  • 病例患者中位年龄52岁(范围1-86岁),52%为男性。
  • 多数病例(70%)发生于6-9月,8月为高峰。
  • 发热和头痛为常见症状;28%的病例患者报告反复发热,55%有关节痛,16%有皮疹。
  • 13%的患者住院,无死亡报告。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Borrelia miyamotoi, transmitted by Ixodes spp. ticks, was recognized as an agent of hard tick relapsing fever in the United States in 2013. Nine state health departments in the Northeast and Midwest have conducted public health surveillance for this emerging condition by using a shared, working surveillance case definition. During 2013-2019, a total of 300 cases were identified through surveillance; 166 (55%) were classified as confirmed and 134 (45%) as possible. Median age of case-patients was 52 years (range 1-86 years); 52% were male. Most cases (70%) occurred during June-September, with a peak in August. Fever and headache were common symptoms; 28% of case-patients reported recurring fevers, 55% had arthralgia, and 16% had a rash. Thirteen percent of patients were hospitalized, and no deaths were reported. Ongoing surveillance will improve understanding of the incidence and clinical severity of this emerging disease.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. McCormick DW, Brown CM, Bjork J, et al. Characteristics of Hard Tick Relapsing Fever Caused by Borrelia miyamotoi, United States, 2013-2019. Emerg Infect Dis. 2023. PMID: 37610298. doi:10.3201/eid2909.221912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。